RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
This Quarter Return
+8.21%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$337M
AUM Growth
+$8.75M
(+2.7%)
Cap. Flow
-$9.97M
Cap. Flow
% of AUM
-2.96%
Top 10 Holdings %
Top 10 Hldgs %
34.36%
Holding
108
New
18
Increased
35
Reduced
37
Closed
12
Top Buys
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
$11.4M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
$9.62M |
| 3 |
Cardinal Health
CAH
|
$6.79M |
| 4 |
AGN
Allergan plc
AGN
|
$5.58M |
| 5 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$3.73M |
Top Sells
| 1 |
Pfizer
PFE
|
$11.3M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
$9.4M |
| 3 |
Gilead Sciences
GILD
|
$5.7M |
| 4 |
CFNL
Cardinal Financial Corp
CFNL
|
$5.03M |
| 5 |
FRX
FOREST LABORATORIES INC
FRX
|
$4.44M |
Sector Composition
| 1 | Healthcare | 85% |
| 2 | Financials | 1.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Supernus Pharmaceuticals
SUPN
$2.52B
| $2.49M | 0.74% |
227,000
+30,463
| +15% | +$334K |
|
|
ARIA
52
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $2.48M | 0.74% |
390,000
+152,190
| +64% | +$969K |
|
|
THOR
53
DELISTED
THORATEC CORPORATION
THOR
| $2.35M | 0.7% |
67,500
-1,288
| -2% | -$44.9K |
|
|
IDIX
54
DELISTED
IDENIX PHARMACEUTICALS INC
IDIX
| $2.34M | 0.69% |
+97,100
| New | +$2.34M |
|
55
Zimmer Biomet
ZBH
$20.8B
| $2.34M | 0.69% |
+23,175
| New | +$2.34M |
|
|
CFN
56
DELISTED
CAREFUSION CORPORATION
CFN
| $2.22M | 0.66% |
50,000
+10,692
| +27% | +$474K |
|
|
NPSP
57
DELISTED
NPS PHARMACEUTICALS INC
NPSP
| $2.21M | 0.66% |
67,000
-99,970
| -60% | -$3.3M |
|
58
Aflac
AFL
$57.1B
| $2.21M | 0.66% |
+71,000
| New | +$2.21M |
|
|
BCR
59
DELISTED
CR Bard Inc.
BCR
| $2.15M | 0.64% |
+15,000
| New | +$2.15M |
|
60
Cencora
COR
$57.2B
| $2.07M | 0.61% |
28,500
-6,500
| -19% | -$472K |
|
61
Masimo
MASI
$7.43B
| $2.05M | 0.61% |
87,000
+23,125
| +36% | +$546K |
|
62
Dynavax Technologies
DVAX
$1.19B
| $1.97M | 0.58% |
122,835
| – | – |
|
|
OCR
63
DELISTED
OMNICARE INC
OCR
| $1.9M | 0.56% |
28,500
-10,808
| -27% | -$719K |
|
|
RAD
64
DELISTED
Rite Aid Corporation
RAD
| $1.86M | 0.55% |
13,000
-4,240
| -25% | -$608K |
|
|
OREX
65
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $1.86M | 0.55% |
30,020
-2,900
| -9% | -$179K |
|
66
Hologic
HOLX
$14.7B
| $1.85M | 0.55% |
+73,000
| New | +$1.85M |
|
|
HPTX
67
DELISTED
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
| $1.84M | 0.55% |
70,369
-3,333
| -5% | -$87K |
|
|
CERN
68
DELISTED
Cerner Corp
CERN
| $1.81M | 0.54% |
+35,000
| New | +$1.81M |
|
69
Amgen
AMGN
$153B
| $1.78M | 0.53% |
15,000
-31,135
| -67% | -$3.69M |
|
70
Pediatrix Medical
MD
$1.45B
| $1.75M | 0.52% |
+30,000
| New | +$1.75M |
|
|
TSRO
71
DELISTED
TESARO, Inc.
TSRO
| $1.71M | 0.51% |
+55,000
| New | +$1.71M |
|
|
CPHD
72
DELISTED
Cepheid Inc
CPHD
| $1.68M | 0.5% |
35,000
-4,308
| -11% | -$207K |
|
|
ITCI
73
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $1.66M | 0.49% |
98,269
| – | – |
|
|
ARRY
74
DELISTED
Array Biopharma Inc
ARRY
| $1.5M | 0.45% |
329,199
| – | – |
|
|
INFI
75
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $1.44M | 0.43% |
113,273
-19,493
| -15% | -$248K |
|